Patient Quality of Life

ACS CAN advocates for policies that improve the lives of cancer patients by making treatment of their pain and other symptoms and coordination of their care standard protocol throughout their treatment for cancer, starting at the point of diagnosis.
 

Featured Resources

 

Patient Quality of Life Resources:

ACS CAN submitted comments to FDA regarding the use of opioids at higher doses, in response to an FDA request for comments. 

This table lists key studies and review articles that examine the effect that the addition of palliative care has on overall patient costs. While results vary, the addition of palliative care typically either reduces overall costs or is cost neutral.

 

In the fall of 2018 the House and Senate passed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (the SUPPORT Act)1 comprehensive legislation to address the opioid epidemic.

A recent flood of legislation meant to curb opioid abuse is inadvertently making it harder for cancer patients and survivors to get legitimate pain care. ACS CAN’s State Pain Policy Report Card evaluates the level of balance states are striking in the pain policies they’re passing.

 

The Comprehensive Addiction and Recovery Act was signed into law on July 22, 2016. CARA was the first major legislative effort focused on addressing the opioid epidemic in the U.S.

ACS CAN supports balanced policies that address the public health concerns relevant to the opioid epidemic,  that do not harm patient access to  medications that they need to treat pain appropriately. 

ACS CAN submitted comments to FDA regarding questions relevant to the newly formed FDA Opioid Policy Steering Committee.